Macrophages Synthesize Factor X and Secrete Factor X/Xa-containing Prothrombinase Activity into the Surrounding Medium

Gunnar Pejler; Carolina Lunderius; Bianca Tomasini-Johansson

doi:10.1055/s-0037-1614040

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2000; 84(03): 429-435
DOI: 10.1055/s-0037-1614040

Commentary

Schattauer GmbH

Macrophages Synthesize Factor X and Secrete Factor X/Xa-containing Prothrombinase Activity into the Surrounding Medium

Gunnar Pejler

¹From the Swedish University of Agricultural Sciences, Department of Veterinary Medical Chemistry, The Biomedical Center, Uppsala, Sweden

,

Carolina Lunderius

²Uppsala University, Department of Cell and Molecular Biology, Uppsala, Sweden

,

Bianca Tomasini-Johansson

¹From the Swedish University of Agricultural Sciences, Department of Veterinary Medical Chemistry, The Biomedical Center, Uppsala, Sweden

³University of Wisconsin-Madison, Department of Medicine, Madison, USA

› Institutsangaben

Abstract

Summary

Activation of the coagulation cascade, mediated by various monocyte/macrophage procoagulants, is an important component in the pathology of inflammatory disease. The type of procoagulant expressed may vary between different monocyte/macrophage subtypes and may differ depending on how the cells are treated. In the present study we show that both murine peritoneal macrophages and human adherent synovial cells from rheumatoid arthritis lesions express prothrombinase activity that was inhibited by anti-Factor X antibodies. Northern blot analysis showed that Factor X was transcribed by the murine peritoneal cells and Western blot analysis showed the presence of Factor X antigen. Further experiments showed that the prothrombinase activity was secreted by the cells into the medium in a detergent-sensitive form, suggesting that the prothrombinase is released on small lipid-containing vesicles.

Key words

Macrophage - prothrombinase - Factor X - thrombin

Volltext

Referenzen

References
1 Østerud B. Tissue factor expression by monocytes: regulation and pathophysiological roles. Blood Coagul Fibrinolysis 1998; 09 (Suppl. 01) S9-14.
2 Dindzans VJ, MacPhee PJ, Fung LS, Leibowitz JL, Levy GA. The immune response to mouse hepatitis virus: expression of monocyte procoagulant activity and plasminogen activator during infection in vivo. J Immunol 1985; 135: 4189-97.
3 Cole EH, Schulman J, Urowitz M, Keystone E, Williams C, Levy GA. Monocyte procoagulant activity in glomerulonephritis associated with systemic lupus erythematosus. J Clin Invest 1985; 75: 861-8.
4 Cole EH, Cardella CJ, Schulman J, Levy GA. Monocyte procoagulant activity and plasminogen activator. Role in human renal allograft rejection. Transplantation 1985; 40: 363-71.
5 Zacharski LR, Brown FE, Memoli VA. et al. Pathways of coagulation activation in situ in rheumatoid synovial tissue. Clin Immunol Immunopathol 1992; 63: 155-62.
6 Lewis JC, Bennett-Cain AL, DeMars CS. et al. Procoagulant activity after exposure of monocyte-derived macrophages to minimally oxidized low density lipoprotein. Co-localization of tissue factor antigen and nascent fibrin fibers at the cell surface. Am J Pathol 1995; 147: 1029-40.
7 Hopper KE, Geczy CL, Davies WA. A mechanism of migration inhibition in delayed-type hypersensitivity reactions. I. Fibrin deposition on the surface of elicited peritoneal macrophages on vivo. J Immunol 1981; 126: 1052-8.
8 Drake TA, Ruf W, Morrissey JH, Edgington TS. Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line. J Cell Biol 1989; 109: 389-95.
9 Edgington TS, Mackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost 1991; 66: 67-79.
10 Gregory SA, Morrissey JH, Edgington TS. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol 1989; 09: 2752-5.
11 McGee MP, Devlin R, Saluta G, Koren H. Tissue factor and factor VII messenger RNAs in human alveolar macrophages: effects of breathing ozone. Blood 1990; 75: 122-7.
12 Nakstad B, Haugen T, Skjonsberg OH, Lyberg T. Expression of leukocyte integrins and tissue factor in mononuclear phagocytes. Eur Respir J 1998; 12: 601-6.
13 Østerud B. Cellular interactions in tissue factor expression by blood monocytes. Blood Coagul Fibrinolysis 1995; 06 (Suppl. 01) S20-5.
14 Tenno T, Botling J, Oberg F, Nilsson K, Siegbahn A. Tissue factor expression in human monocytic cell lines. Thromb Res 1997; 88: 215-28.
15 van den Eijnden MM, Steenhauer SI, Reitsma PH, Bertina RM. Tissue factor expression during monocyte-macrophage differentiation. Thromb Haemost 1997; 77: 1129-36.
16 Chapman Jr HA, Allen CL, Stone OL, Fair DS. Human alveolar macrophages synthesize factor VII in vitro. Possible role in interstitial lung disease. J Clin Invest 1985; 75: 2030-7.
17 McGee MP, Wallin R, Devlin R, Rothberger H. Identification of mRNA coding for factor VII protein in human alveolar macrophages-coagulant expression may be limited due to deficient postribosomal processing. Thromb Haemost 1989; 61: 170-4.
18 Altieri DC, Edgington TS. Sequential receptor cascade for coagulation proteins on monocytes. Constitutive biosynthesis and functional prothrombinase activity of a membrane form of factor V/Va. J Biol Chem 1989; 264: 2969-72.
19 Østerud B, Bøgwald J, Lindahl U, Seljelid R. Production of blood coagulation factor V and tissue thromboplastin by macrophages in vitro. FEBS Lett 1981; 127: 154-60.
20 Østerud B, Lindahl U, Seljelid R. Macrophages produce blood coagulation factors. FEBS Lett 1980; 120: 41-3.
21 Lindahl U, Kolset SO, Bøgwald J, Østerud B, Seljelid R. Studies, with a luminogenic peptide substrate, on blood coagulation factor X/Xa produced by mouse peritoneal macrophages. Biochem J 1982; 206: 231-7.
22 Altieri DC, Morrissey JH, Edgington TS. Adhesive receptor Mac-1 coordinates the activation of factor X on stimulated cells of monocytic and myeloid differentiation: an alternative initiation of the coagulation protease cascade. Proc Natl Acad Sci USA 1988; 85: 7462-6.
23 Plescia J, Altieri DC. Activation of Mac-1 (CD11b/CD18)-bound factor X by released cathepsin G defines an alternative pathway of leucocyte initiation of coagulation. Biochem J 1996; 319: 873-9.
24 Fung LS, Neil G, Leibowitz J. et al. Monoclonal antibody analysis of a unique macrophage procoagulant activity induced by murine hepatitis virus strain 3 infection. J Biol Chem 1991; 266: 1789-95.
25 Parr RL, Fung L, Reneker J, Myers-Mason N, Leibowitz JL, Levy G. Association of mouse fibrinogen-like protein with murine hepatitis virusinduced prothrombinase activity. J Virol 1995; 69: 5033-8.
26 Parr RL, Fung L, Reneker J, Myers-Mason N, Leibowitz JL, Levy G. MHV-3 induced prothrombinase is encoded by musfiblp. Adv Exp Med Biol 1995; 380: 151-7.
27 Tomasini-Johansson BR, Milbrink J, Pejler G. Vitronectin expression in rheumatoid arthritic synovia-inhibition of plasmin generation by vitronectin produced in vitro. Br J Rheumatol 1998; 37: 620-9.
28 Liang Z, Cooper A, DeFord ME. et al. Cloning and characterization of a cDNA encoding murine coagulation factor X. Thromb Haemost 1998; 80: 87-91.
29 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
30 Lützelschwab C, Huang MR, Kullberg MC, Aveskogh M, Hellman L. Characterization of mouse mast cell protease-8, the first member of a novel subfamily of mouse mast cell serine proteases, distinct from both the classical chymases and tryptases. Eur J Immunol 1998; 28: 1022-33.
31 Minty AJ, Caravatti M, Robert B. et al. Mouse actin messenger RNAs. Construction and characterization of a recombinant plasmid molecule containing a complementary DNA transcript of mouse alpha-actin mRNA. J Biol Chem 1981; 256: 1008-14.
32 Lindahl U, Pejler G, Bøgwald J, Seljelid R. A prothrombinase complex of mouse peritoneal macrophages. Arch Biochem Biophys 1989; 273: 180-8.
33 Stanton C, Wallin R. Processing and trafficking of clotting factor X in the secretory pathway. Effects of warfarin. Biochem J 1992; 284: 25-31.
34 Tracy PB, Robinson RA, Worfolk LA, Allen DH. Procoagulant activities expressed by peripheral blood mononuclear cells. Methods Enzymol 1993; 222: 281-99.
35 Schwartz BS, Levy GA, Fair DS, Edgington TS. Murine lymphoid procoagulant activity induced by bacterial lipopolysaccharide and immune complexes is a monocyte prothrombinase. J Exp Med 1982; 155: 1464-79.
36 Schwartz BS, Levy GA, Curtiss LK, Fair DS, Edgington TS. Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro: two procoagulant activities are produced by peripheral blood mononuclear cells. J Clin Invest 1981; 67: 1650-8.
37 Chung S, Sinclair S, Leibowitz J, Skamene E, Fung LS, Levy G. Cellular and metabolic requirements for induction of macrophage procoagulant activity by murine hepatitis virus strain 3 in vitro. J Immunol 1991; 146: 271-8.
38 Mann KG, Jenny RJ, Krishnaswamy S. Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Annu Rev Biochem 1988; 57: 915-56.
39 Pejler G. Procoagulant and anticoagulant activities of resident and inflammatory peritoneal cells. Inflamm Res 1999; 48: 344-50.
40 Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 1989; 264: 17049-57.
41 Chang CP, Zhao J, Wiedmer T, Sims PJ. Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylserine. J Biol Chem 1993; 268: 7171-8.
42 Dery O, Corvera CU, Steinhoff M, Bunnett NW. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol 1998; 274: C1429-52.
43 Bar-Shavit R, Kahn A, Fenton JWd, Wilner GD. Chemotactic response of monocytes to thrombin. J Cell Biol 1983; 96: 282-5.
44 Hattori R, Hamilton KK, Fugate RD, McEver RP, Sims PJ. Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J Biol Chem 1989; 264: 7768-71.
45 Aschner JL, Lennon JM, Fenton JWd, Aschner M, Malik AB. Enzymatic activity is necessary for thrombin-mediated increase in endothelial permeability. Am J Physiol 1990; 259: L270-5.
46 Razin E, Baranes D, Marx G. Thrombin-mast cell interactions. Binding and cell activation. Exp Cell Res 1985; 160: 380-6.